Carasent ASA Share Price Nasdaq Stockholm
Stocks
CARAO
NO0010123060
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 1.67B 176M 153M 142M 131M 247M 16.79B 251M 1.68B 658M 8.36B 660M 646M 28.02B | P/E 2026 * |
73.4x | P/E 2027 * | 29.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.67B 176M 153M 143M 131M 248M 16.85B 251M 1.68B 661M 8.39B 663M 648M 28.12B | EV / Sales 2026 * |
3.95x | EV / Sales 2027 * | 3.09x |
| Free-Float |
65.26% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent ASA
| 1 day | -3.90% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | -54.08% | - | - | 175M | |
| +1.16% | +9.02% | -28.56% | -0.58% | 32.74B | |
| +0.94% | +0.05% | -49.27% | +134.14% | 11.77B | |
| -4.23% | +0.53% | -26.39% | +58.48% | 5.63B | |
| -1.99% | +5.18% | - | - | 2.23B | |
| -2.79% | -11.50% | +17.01% | -42.54% | 1.69B | |
| -0.86% | +3.73% | - | - | 1.8B | |
| +3.26% | -1.16% | -34.17% | - | 1.01B | |
| -3.06% | -2.40% | +30.34% | +97.00% | 871M | |
| +6.25% | +7.85% | -38.34% | -51.63% | 770M | |
| Average | -0.51% | +1.51% | -18.48% | +32.48% | 6.5B | |
| Weighted average by Cap. | +0.34% | +6.39% | -30.70% | +34.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 424M 44.73M 38.88M 36.19M 33.23M 62.75M 4.27B 63.72M 427M 167M 2.13B 168M 164M 7.13B | 516M 54.38M 47.27M 44M 40.4M 76.29M 5.19B 77.47M 519M 204M 2.58B 204M 200M 8.67B |
| Net income | 24.2M 2.55M 2.22M 2.06M 1.89M 3.58M 243M 3.63M 24.33M 9.55M 121M 9.58M 9.37M 406M | 60.96M 6.42M 5.59M 5.2M 4.77M 9.01M 613M 9.15M 61.28M 24.05M 305M 24.13M 23.6M 1.02B |
| Net Debt | 5.87M 619K 538K 501K 460K 868K 59.1M 882K 5.9M 2.32M 29.42M 2.32M 2.27M 98.65M | -73.31M -7.73M -6.72M -6.25M -5.74M -10.84M -738M -11.01M -73.7M -28.92M -367M -29.02M -28.38M -1.23B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
